1. Home
  2. ITT vs SRPT Comparison

ITT vs SRPT Comparison

Compare ITT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITT
  • SRPT
  • Stock Information
  • Founded
  • ITT 1920
  • SRPT 1980
  • Country
  • ITT United States
  • SRPT United States
  • Employees
  • ITT N/A
  • SRPT N/A
  • Industry
  • ITT Fluid Controls
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITT Industrials
  • SRPT Health Care
  • Exchange
  • ITT Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • ITT 12.4B
  • SRPT 12.2B
  • IPO Year
  • ITT N/A
  • SRPT 1997
  • Fundamental
  • Price
  • ITT $155.41
  • SRPT $109.96
  • Analyst Decision
  • ITT Strong Buy
  • SRPT Strong Buy
  • Analyst Count
  • ITT 9
  • SRPT 21
  • Target Price
  • ITT $157.89
  • SRPT $182.00
  • AVG Volume (30 Days)
  • ITT 441.1K
  • SRPT 1.1M
  • Earning Date
  • ITT 10-29-2024
  • SRPT 11-06-2024
  • Dividend Yield
  • ITT 0.82%
  • SRPT N/A
  • EPS Growth
  • ITT 11.49
  • SRPT N/A
  • EPS
  • ITT 5.85
  • SRPT 1.22
  • Revenue
  • ITT $3,530,800,000.00
  • SRPT $1,640,348,000.00
  • Revenue This Year
  • ITT $11.61
  • SRPT $45.98
  • Revenue Next Year
  • ITT $7.15
  • SRPT $78.13
  • P/E Ratio
  • ITT $26.59
  • SRPT $90.59
  • Revenue Growth
  • ITT 9.36
  • SRPT 48.45
  • 52 Week Low
  • ITT $107.01
  • SRPT $78.67
  • 52 Week High
  • ITT $156.00
  • SRPT $173.25
  • Technical
  • Relative Strength Index (RSI)
  • ITT 62.91
  • SRPT 36.68
  • Support Level
  • ITT $149.65
  • SRPT $102.16
  • Resistance Level
  • ITT $154.15
  • SRPT $122.63
  • Average True Range (ATR)
  • ITT 3.01
  • SRPT 5.06
  • MACD
  • ITT 0.37
  • SRPT -1.13
  • Stochastic Oscillator
  • ITT 96.33
  • SRPT 25.44

About ITT ITT Inc.

ITT Inc is a diversified manufacturer of engineered critical components and customized technology solutions predominantly for the transportation, industrial and energy markets. The company's products include, brake pads, shock absorbers, pumps, valves, connectors, switches and others. Its operating segments are; Motion Technologies (MT), Industrial Process (IP), and Connect & Control Technologies (CCT). The majority of the revenue is generated from the Motion Technologies segment which is a manufacturer of brake pads, shims, shock absorbers, energy absorption components and sealing technologies. Geographically, the company generates majority of the revenue from North America, and also has its presence in South America, Europe, Asia, Middle East and Africa.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

Share on Social Networks: